Asthma Clinical Trial
Official title:
Innovative Asthma Education Using a Unique Blend of Child Life Services and an Asthma-based Computer Game in the Pediatric Emergency Room
This is a single center pilot study designed to evaluate the effectiveness of an asthma
education program in the pediatric emergency department. Asthma has reached epidemic
proportions. Nine million American children are affected in the United States alone. This
problem has increased 75% from 1980 to 1994, with a staggering 160% increase seen in children
less than five years old.1 The American Lung Association has targeted this overwhelming
problem on both national and local levels. Asthma impacts American communities who differ
geographically, culturally, ethnically and by lifestyle, and as a result will present with
different obstacles.
The primary objectives are: to determine whether this educational intervention (through
interactions with a child life specialist and using the asthma based computer game) in the
pediatric ED can influence children's [and care givers'] knowledge and understanding of the
disease process and treatment, and to improve asthma self-management and decrease morbidity
by decreasing ED use and hospitalization.
A secondary objective is to introduce the Child Life Specialist as an effective asthma
educator and further strengthen the health care team.
The target population will be recruited from the pediatric emergency department. We
anticipate this study to recruit over a one year period and have a one year follow up with an
anticipated enrollment of 64 children and families. There will be three Child Life Specialist
involved in this program.
After consent has been obtained, the child and parent will complete questionnaires (focusing
on asthma knowledge, quality of life, and perception of asthma) and then a laptop will be
provided to access the asthma based computer game.
During the child's ED visit the Child Life Specialist will have opportunities to open
communication to address barriers or concerns, and reinforce material provided by the game.
Through these interactions, the importance of communication between the child, parent and
healthcare provider is highlighted.
The family will be given information to access the computer game via the internet. Follow up
phone calls or e-mails will occur at 6 months, 9 months, and 12 months which will entail
completing questionnaires. The questionnaires uses validated questions along with questions
from the material covered through this asthma education study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|